Meet the developers behind the Pfizer building conversion
New York City turned its eyes towards the former Pfizer building in Midtown East Tuesday morning, but not for the reason the developers would’ve hoped. Reports emerged before 8 a.m. of debris falling from the construction site at 235 East 42nd Street, arguably the country’s most notable office-to-residential conversion post-pandemic to unfold. As of midday, concerns about the safety of the building remain as columns within the building buckle, forcing evacuations and street closures in and around the property. It’s not the first notable incident at the project, which commanded real estate’s attention long before pedestrians were forced to steer […]
This article originally appeared on The Real Deal. Click here to read the full story.
Categories
Recent Posts

Meg Ryan sells Bridgehampton home to Broadway
producer

Gary Barnett eyeing $3.8B loan for UWS supertall
project

Legion Investment Group, SMA Equities partner on new UES
resi development

Floyd Mayweather drops lawsuit against Jona Rechnitz

Climbing mortgage rates widen NYC’s buyer divide

The Correction Will Get Even More Severe | Sept. 2026
Housing Market Update

You’ve Got a 100% Financing Deal. Do You Take It? (Rookie
Reply)

NY Dirt: Phones to be searched as judge weighs rent
freeze

Cushman, Newmark win REBNY Retail Deal of the Year
Awards

STK steakhouse chain cooks up lawsuit in Union
Square


